News
9don MSN
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
3h
IFLScience on MSNA blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly ...
The Department of Health and Human Services, which oversees FDA and other health agencies, did not immediately respond to a ...
WASHINGTON — The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results